Our analysis revealed a positive correlation between RASD1 expression and CD4+ T cells (Figure 6a–c) and myeloid dendritic cells (Figure 6d–f) in KIRC, LGG, and PAAD. This evidence concerns the gene RASD1 and pancreatic adenocarcinoma.